Louise Pettersson
1 – 10 of 10
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2024
- 
                        Mark
        Factors affecting hospitalization and mortality in a retrospective study of elderly patients with heart failure
    
    - Contribution to journal › Article
 
- 
                        Mark
        The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
    (2021) In International Journal of Laboratory Hematology- Contribution to journal › Article
 
- 
                        Mark
        Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
    
    - Contribution to journal › Article
 
- 
                        Mark
        Measurable residual disease and clonal evolution in acute myeloid leukemia with focus on NPM1-mutations
    (2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Thesis › Doctoral thesis (compilation)
 
- 2020
- 
                        Mark
        Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Measurable residual disease testing for personalized treatment of acute myeloid leukemia
    
    - Contribution to journal › Scientific review
 
- 2018
- 
                        Mark
        Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow
    
    - Contribution to journal › Letter
 
- 2017
- 
                        Mark
        Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
    
    - Contribution to journal › Article
 
- 2016
- 
                        Mark
        Improved minimal residual disease detection by targeted quantitative polymerase chain reaction in Nucleophosmin 1 type a mutated acute myeloid leukemia
    
    - Contribution to journal › Article
 
